NCT06554548View on ClinicalTrials.gov

A Study Evaluating Food Effect on Pharmacokinetics of HS-10518

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 15, 2024

Primary Completion Date

July 30, 2025

Study Completion Date

August 30, 2025

Conditions

Endometriosis

Interventions

DRUG

HS-10518

Treatment A: Single oral dose of HS-10518 160 mg tablet under fasted conditions Treatment B: Single oral dose of HS-10518 160 mg tablet after a high-fat meal